Greenwich LifeSciences GLSI Stock
Greenwich LifeSciences Price Chart
Greenwich LifeSciences GLSI Financial and Trading Overview
| Greenwich LifeSciences stock price | 19.24 USD |
| Previous Close | 19.8 USD |
| Open | 19.6 USD |
| Bid | 14.4 USD x 200 |
| Ask | 23.36 USD x 200 |
| Day's Range | 18.22 - 19.92 USD |
| 52 Week Range | 7.78 - 34.1 USD |
| Volume | 109.14K USD |
| Avg. Volume | 144.59K USD |
| Market Cap | 272.57M USD |
| Beta (5Y Monthly) | 1.393 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -1.61 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 47.5 USD |
GLSI Valuation Measures
| Enterprise Value | 262.07M USD |
| Trailing P/E | N/A |
| Forward P/E | -22.646341 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 51.72702 |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | -11.698 |
Trading Information
Greenwich LifeSciences Stock Price History
| Beta (5Y Monthly) | 1.393 |
| 52-Week Change | 84.22% |
| S&P500 52-Week Change | 20.36% |
| 52 Week High | 34.1 USD |
| 52 Week Low | 7.78 USD |
| 50-Day Moving Average | 23.62 USD |
| 200-Day Moving Average | 19.93 USD |
GLSI Share Statistics
| Avg. Volume (3 month) | 144.59K USD |
| Avg. Daily Volume (10-Days) | 142.38K USD |
| Shares Outstanding | 14.68M |
| Float | 7.39M |
| Short Ratio | 8.68 |
| % Held by Insiders | 47.86% |
| % Held by Institutions | 12.48% |
| Shares Short | 1.46M |
| Short % of Float | 19.04% |
| Short % of Shares Outstanding | 9.93% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2025 |
| Most Recent Quarter (mrq) | March 31, 2026 |
| Next Fiscal Year End | December 31, 2026 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -211.26% |
| Return on Equity (ttm) | -676.65% |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | -22403600 USD |
| Net Income Avi to Common (ttm) | -22270576 USD |
| Diluted EPS (ttm) | -1.61 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 10.51M USD |
| Total Cash Per Share (mrq) | 0.72 USD |
| Total Debt (mrq) | 0 USD |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 2.007 |
| Book Value Per Share (mrq) | 0.359 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -12781497 USD |
| Levered Free Cash Flow (ttm) | -3402170 USD |
Profile of Greenwich LifeSciences
| Country | United States |
| State | TX |
| City | Stafford |
| Address | Building 14 |
| ZIP | 77477 |
| Phone | 832-819-3232 |
| Website | https://greenwichlifesciences.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | N/A |
Greenwich LifeSciences, Inc., a clinical-stage biopharmaceutical company, develops novel cancer immunotherapies for breast cancer and other HER2/neu-expressing cancers in the United States. Its lead product candidate is GP2, a HER2/neu transmembrane peptide, which is in Phase III clinical trial to prevent breast cancer recurrences in patients. The company also develops FLAMINGO-01, which is in Phase IIb and 3 Phase I clinical trial designed to evaluate the safety and efficacy of GLSI-100 in HER2 positive breast cancer patients. Greenwich LifeSciences, Inc. was formerly known as Norwell, Inc. and changed its name to Greenwich LifeSciences, Inc. in March 2018. The company was incorporated in 2006 and is headquartered in Stafford, Texas.
Q&A For Greenwich LifeSciences Stock
What is a current GLSI stock price?
Greenwich LifeSciences GLSI stock price today per share is 19.24 USD.
How to purchase Greenwich LifeSciences stock?
You can buy GLSI shares on the Tech Market Small exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Greenwich LifeSciences?
The stock symbol or ticker of Greenwich LifeSciences is GLSI.
Which industry does the Greenwich LifeSciences company belong to?
The Greenwich LifeSciences industry is Biotechnology.
How many shares does Greenwich LifeSciences have in circulation?
The max supply of Greenwich LifeSciences shares is 14.68M.
What is Greenwich LifeSciences Price to Earnings Ratio (PE Ratio)?
Greenwich LifeSciences PE Ratio is now.
What was Greenwich LifeSciences earnings per share over the trailing 12 months (TTM)?
Greenwich LifeSciences EPS is -1.61 USD over the trailing 12 months.
Which sector does the Greenwich LifeSciences company belong to?
The Greenwich LifeSciences sector is Healthcare.
Greenwich LifeSciences GLSI included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
|
|
{{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
US Tech Composite
IXIC
US
|
26090.48 USD — |
-0.06
|
3.04B USD — | 26087.43 USD — | 26316.81 USD — | — - | 3.04B USD — |
|
US Tech Health Care
IXHC
US
|
1250.55 USD — |
+0.75
|
— — | 1233.72 USD — | 1252.43 USD — | — - | — — |
- {{ link.label }} {{link}}